Wed, March 10, 2021
Tue, March 9, 2021
Mon, March 8, 2021

Neena Bitritto-Garg Downgraded (ACAD) to Hold and Decreased Target to $35 on, Mar 9th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-35-on-mar-9th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Neena Bitritto-Garg of Citigroup, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Decreased Target from $66 to $35 on, Mar 9th, 2021.

Neena has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Neena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Neena


  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020